corticosteroid dermatitis or allergic dermatitis
Conditions
Interventions
C0:Topical drug-free cream base
C1:Topical 0.5% eucalyptol cream
C2:Topical 1% eucalyptol cream
C3:Topical 2% eucalyptol cream
U0:Topical drug-free ointment base
U1:Topical 2% eucalyptol ointment
U2:Topical 1% eucalyptol ointment
U3:Topical 2% eucalyptol ointment
Sponsors
Guangzhou Institute of Dermatology
Eligibility
Sex/Gender
All
Age
6 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. A newly diagnosed patient with mild to face hormone-dependent dermatitis and atopic dermatitis on the face, elbow fossa, and knee joint; 2. The person or guardian voluntarily signs the informed consent form; 3. When the age is more than 6 years old, female patients need to exclude pregnancy, breastfeeding and recent consideration of pregnancy; 4. Good liver and kidney function; 5. Good compliance;
Exclusion criteria
Exclusion criteria: 1. Diseases that have other serious diseases or are not suitable for this clinical trial; 2. Need to take other drugs that may affect the results after the visit; 3. Those who may be allergic to the test drug or the preparation matrix.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial physiological indicators test (fat, moisture, transepidermal water loss, pH, elasticity);Facial Visa test; | — |
Countries
China
Contacts
Public ContactXingdong Ye
Guangzhou Institute of Dermatology
Outcome results
None listed